IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,000 | -34.2% | 2,283 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $38,000 | -33.3% | 2,283 | -23.2% | 0.00% | -33.3% |
| Q4 2021 | $57,000 | -27.8% | 2,971 | -6.7% | 0.00% | -40.0% |
| Q3 2021 | $79,000 | -6.0% | 3,183 | -1.9% | 0.01% | 0.0% |
| Q2 2021 | $84,000 | -57.8% | 3,246 | -48.4% | 0.01% | -64.3% |
| Q1 2021 | $199,000 | -64.2% | 6,285 | -47.5% | 0.01% | -68.9% |
| Q4 2020 | $556,000 | +42.6% | 11,980 | +1.2% | 0.04% | +36.4% |
| Q3 2020 | $390,000 | +25.0% | 11,840 | +4.0% | 0.03% | +32.0% |
| Q2 2020 | $312,000 | +169.0% | 11,390 | +193.6% | 0.02% | +127.3% |
| Q1 2020 | $116,000 | +1350.0% | 3,880 | +385.0% | 0.01% | +1000.0% |
| Q1 2019 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |